Physical map of the target region and graphical genotypes and resistance phenotypes of the sub-CSSLs.

<p>The open bars, solid bars and gray bars represent H359, H359-BLSR5A and recombined segments, respectively. The vertical solid/dotted lines indicate molecular marker positions. The lowercase and uppercase letters after the lesion length indicate statistical difference at 0.05 and 0.01 significance levels, respectively. R/S: resistant/susceptible to BLS.</p

Comparison of the coding sequences of gene LOC_Os05g01710 from the two parents.

<p>Asterisks indicate the substituted nucleotides.</p

InDel markers developed in this study.

<p>InDel markers developed in this study.</p

Primers used for coding sequence amplification and qRT-PCR analysis.

<p>Note: For each putative gene, primers for coding sequence amplification are shown in the upper row; primers for qRT-PCR are shown in the lower row. The primers for Actin gene were used for qRT-PCR.</p

Expression response of LOC_Os05g01700 (A), LOC_Os05g01710 (B) and LOC_Os05g01730 (C) to BLS pathogen in the two parents.

<p>The expression is thought to be significantly up−/down-regulated when the relative expression intensity, defined as log₂[(expression intensity in treatment)/(expression intensity in control)], is greater/smaller than 1/−1.</p